BCBA/GILDD (BCBA/GILDD)

Buenos Aires Stock Exchange: BCBA/GILDD · USD

$42.2

+0.03 (+0.1%)· Recorded snapshot

Market cap	303.4T
Revenue (ttm)	45.1T
Net income (ttm)	-4.8T
EPS (ttm)	-$1,006
P/E (forward)	18.7x
Dividend	$717 (1.10%)
Volume	2

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 45.1T
Net income (ttm): -4.8T
EPS (ttm): -$1,006
P/E (forward): 18.7x
Market cap: 303.4T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.7

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-20.7

P25 n/aP50 n/aP75 n/a

ROIC34.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/GILDD indicators

Market & fundamental data

Available fields

219

Groups with data

Currency

USD

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-29
Employees	17,000
Employees change	-600
Employees growth	-3.41%
Enterprise value	$336.2T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1987
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARBCOM4601C4
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Market cap	$303.4T
Next earnings date	2026-10-29
Price	$42.22
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	bcba/GILDD
Website	https://www.gilead.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	75.16x
Average P/E ratio (3Y)	133.64x
Average P/E ratio (5Y)	84.97x
Earnings yield	-1.55%
EV/EBIT	18.46x
EV/EBITDA	14.8x
EV/FCF	17.53x
EV/Sales	7.18x
FCF / EV yield	5.7%
FCF yield	6.32%
Forward P/E	18.73x
P/(FCF - SBC) ratio	17.02x
P/(OCF - SBC) ratio	16.2x
P/B ratio	17.44x
P/FCF ratio	15.82x
P/OCF ratio	15.11x
P/S ratio	6.72x
Price/EBITDA ratio	14.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	38.88%
EBITDA margin	47.94%
FCF margin	40.93%
Gross margin	79.6%
Operating margin	38.88%
Pretax margin	-6.42%
Profit margin	-10.64%
Profit per employee	$-282.4M
Profitable years	19
Revenue per employee	$2.7B
ROA	14.09%
ROA (5Y)	10.85%
ROCE	30.88%
ROE	-20.68%
ROE (5Y)	24.33%
ROIC	34.37%
ROIC (5Y)	21.93%
SBC / revenue	2.98%
Tax / revenue	4.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
FCF growth	38.15%
FCF growth (Q)	376.81%
FCF growth (QoQ)	41.45%
FCF growth 3Y	13.19%
FCF growth 5Y	8.85%
Gross profit growth	6.96%
Gross profit growth (Q)	11.52%
Gross profit growth 3Y	3.69%
Gross profit growth 5Y	1.75%
Net income growth years	1
OCF growth	37.33%
OCF growth (Q)	332.04%
OCF growth (QoQ)	40.45%
OCF growth 10Y	-2.84%
OCF growth 3Y	12.52%
OCF growth 5Y	8.31%
Operating income growth	7.34%
Operating income growth (Q)	-5.23%
Operating income growth 3Y	6.62%
Operating income growth 5Y	-1.1%
Revenue growth	5.52%
Revenue growth (Q)	10.18%
Revenue growth (QoQ)	12.11%
Revenue growth 10Y	-0.61%
Revenue growth 3Y	3.61%
Revenue growth 5Y	2.72%
Revenue growth quarters	5
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-902.2B
Depreciation and amortization	$4.2T
EBIT	$17.5T
EBITDA	$21.6T
EPS	$-1,005.63
Financing cash flow	$-6.9T
Free cash flow	$19.2T
Free cash flow minus SBC	$17.8T
Gross profit	$35.9T
Income taxes	$1.9T
Investing cash flow	$-16.1T
Net borrowing	$2T
Net cash flow	$-2.9T
Net income	$-4.8T
Operating cash flow minus SBC	$18.7T
Operating income	$17.5T
Revenue	$45.1T
Stock-based compensation	$1.3T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.05
Book value per share	$14,121.40
Debt / EBITDA	1.78
Debt / equity	2.23
Debt / FCF	2.03
Goodwill	$12.8T
Interest coverage	11.86
Long-term assets	$51.7T
Long-term liabilities	$38.8T
Net cash (debt)	$-31.7T
Net cash / market cap	-10.43%
Net debt / EBITDA	1.46
Net debt / equity	1.82
Net debt / FCF	1.65
Piotroski F-Score	5
Property, plant and equipment	$9T
Shareholders' equity	$17.4T
Tangible book value	$-15.6T
Tangible book value per share	$-12,555.15
Total assets	$73.1T
Total cash	$7.2T
Total debt	$38.9T
Total liabilities	$55.7T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.58
Current assets	$21.5T
Current liabilities	$17T
Current ratio	1.27
Inventory turnover	3.29
Net working capital	$677B
Quick ratio	0.9
Working capital	$4.3T
Working capital turnover	13,982.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.39%
Dividend growth	3.5%
Dividend growth (3Y)	2.93%
Dividend growth years	4
Dividend payment date	2026-09-29
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	$716.75
Dividend yield	1.1%
Ex-dividend date	2026-09-15
Last dividend	$0.13
Shareholder yield	2.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$36.15
1D price change	0.07%
1M price change	6.08%
1M total return	6.08%
1W price change	3.97%
1W total return	3.97%
1Y price change	40.45%
1Y return CAGR	42.93%
1Y total return	42.89%
20-day SMA	$40.03
200-day SMA	$35.26
3M price change	23.56%
3M total return	24.23%
3Y price change	76.65%
3Y return CAGR	23.3%
3Y total return	87.47%
50-day SMA	$38.63
50-day SMA vs 200-day SMA	50over200
52-week high	$42.22
52-week high date	2026-10-27
52-week low	$28.06
52-week low date	2025-10-28
5Y price change	139.89%
5Y return CAGR	21.76%
5Y total return	167.56%
6M price change	24.21%
6M total return	25.4%
All-time high	$42.22
All-time high date	2026-10-27
All-time low	$14.50
All-time low date	2022-04-25
Average true range (ATR)	$0.75
Average volume	37.1
Change from 52-week high	0%
Change from 52-week low	50.46%
Change from all-time high	0%
Change from all-time low	191.17%
Change from open	0%
Day's gap	0.07%
Dollar volume	$84.44
High price	$42.22
Low price	$42.22
Monthly RSI	74.19
Open price	$42.22
Previous close	$42.19
Price vs 150-day SMA	16.8%
Price vs 20-day SMA	5.47%
Price vs 200-day SMA	19.75%
Price vs 50-day SMA	9.31%
Relative volume	0.05
RSI	65.71
Sharpe ratio	1.16
Sortino ratio	1.93
Volume	2
Weekly RSI	68.21
YTD price change	34.97%
YTD total return	36.75%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.2B
Shares change (QoQ)	-0.88%
Shares change (YoY)	-1.39%
Shares held by insiders	0.09%
Shares held by institutions	90.91%
Short ratio	3.3 days

Deeper analysis on BCBA/GILDD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/GILDD report

Is a complete BCBA/GILDD research report available?

No complete published report is available for bcba/GILDD (BCBA/GILDD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/GILDD (BCBA/GILDD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/GILDD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/GILDD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/GILDD

Frequently asked questions